Condensed Consolidated Interim Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Current Assets:
Cash and cash equivalents	$ 54,598	$ 62,545
Accounts receivable, net	24,356	25,855
Prepaid expenses	5,600	6,105
Other current assets	2,093	2,303
Total current assets	86,647	96,808
Property and equipment, net	16,879	15,759
Right-of-use-assets, net	13,438	6,732
Other assets	4,529	4,484
Total assets	121,493	123,783
Current liabilities:
Accounts payable	1,290	1,685
Accrued expenses and other current liabilities	7,403	11,665
Current portion of lease liabilities	5,013	4,030
Total current liabilities	13,706	17,380
Lease liabilities, net of current portion	8,642	2,959
Total liabilities	22,348	20,339
Stockholders' Equity:
Additional paid-in capital	240,075	244,260
Accumulated deficit	(176,012)	(178,863)
Accumulated other comprehensive loss	(473)	(504)
Total stockholders' equity attributable to Enfusion, Inc.	63,705	65,007
Non-controlling interests	35,440	38,437
Total stockholders' equity	99,145	103,444
Total liabilities and stockholders' equity	121,493	123,783
Common Class A
Stockholders' Equity:
Common stock	74	71
Common Class B
Stockholders' Equity:
Common stock	$ 41	$ 43